1 completed, 1 enrolling by invitation, 1 recruiting, 1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Allergen Immunotherapy: new trials by email Literature Review of Allergen Immunotherapy trials Research Report on Allergen Immunotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allergy, Asthma, and Atopic Eczema in Finland No intervention, No Intervention: Observational Cohort - Asthma, Asthma in Children | Enrolling by invitation | Tampere University | 1600000 | 2026-10-01 | 2026-10-27 | |
| Phase 1, First in Human (FIH), Open-Label, Single-Arm, Ascending Dose Study to Assess the Safety, Tolerability and Preliminary Immunogenicity of ITI-9001 in Japanese Patients With Japanese Red Cedar (JRC) Pollinosis ITI-9001, Placebo - Allergen Immunotherapy | Phase 1 | Recruiting | Immunomic Therapeutics, Inc. | 45 | 2026-06-20 | 2026-09-25 |
| Influences of Allergic Rhinitis and Allergen Immunotherapy on SARS-CoV-2 Vaccination There is no intervention in this study. - Allergic Rhinitis, Allergen Immunotherapy | Unknown | Huazhong University of Science and Technology | 120 | 2021-06-04 | 2022-03-17 | |
| Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice Allergen Immunotherapy | Completed | University Hospital, Montpellier | 400 | 2019-09-01 | 2020-12-29 |
Hypersensitivity (2) · Rhinitis, Allergic (2) · Asthma (1) · Dermatitis, Atopic (1) · Respiration Disorders (1) · Rhinitis, Allergic, Seasonal (1)
Respiratory Tract Diseases (4) · Hypersensitivity, Immediate (3) · Immune System Diseases (3) · Nose Diseases (3) · Otorhinolaryngologic Diseases (3) · Respiratory Hypersensitivity (3) · Rhinitis (3) · Bronchial Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dermatitis (1) · Genetic Diseases, Inborn (1) · Hypersensitivity (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Rhinitis, Allergic (1)
Huazhong University of Science and Technology (1) · Immunomic Therapeutics, Inc. (1) · Tampere University (1) · University Hospital, Montpellier (1)
China (1) · Finland (1) · France (1) · Japan (1)
Pascal Demoly (1) · Zheng Liu, Doctor (1)